Form 8-K - Current report:
SEC Accession No. 0001193125-24-266184
Filing Date
2024-11-26
Accepted
2024-11-26 17:02:00
Documents
14
Period of Report
2024-11-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d833314d8k.htm   iXBRL 8-K 34778
2 EX-10.1 d833314dex101.htm EX-10.1 1456305
  Complete submission text file 0001193125-24-266184.txt   1954584

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA jazz-20241126.xsd EX-101.SCH 2860
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE jazz-20241126_lab.xml EX-101.LAB 18690
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jazz-20241126_pre.xml EX-101.PRE 11693
17 EXTRACTED XBRL INSTANCE DOCUMENT d833314d8k_htm.xml XML 3815
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 241505125
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)